{
  "id": "cluster_8_doc2",
  "content": "Pre-authorization request HS-2023-0456 for adalimumab submitted March 10, 2023 by Dr. Ellen Voss at Granite Peak Dermatology. Justification cites failed conventional treatments and positive research outcomes from UCLA's 2022 HS clinical trial.",
  "metadata": {
    "format": "insurance_memo"
  }
}